[go: up one dir, main page]

FR2873295B1 - Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation - Google Patents

Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation

Info

Publication number
FR2873295B1
FR2873295B1 FR0408230A FR0408230A FR2873295B1 FR 2873295 B1 FR2873295 B1 FR 2873295B1 FR 0408230 A FR0408230 A FR 0408230A FR 0408230 A FR0408230 A FR 0408230A FR 2873295 B1 FR2873295 B1 FR 2873295B1
Authority
FR
France
Prior art keywords
inflammation
medicament
preparation
treatment
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0408230A
Other languages
English (en)
Other versions
FR2873295A1 (fr
Inventor
Philippe Msika
Antoine Piccirilli
Nathalie Piccardi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Expanscience SA
Original Assignee
Laboratoires Expanscience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Expanscience SA filed Critical Laboratoires Expanscience SA
Priority to FR0408230A priority Critical patent/FR2873295B1/fr
Priority to EP05790724A priority patent/EP1786384A1/fr
Priority to US11/572,769 priority patent/US20080045594A1/en
Priority to PCT/FR2005/001859 priority patent/WO2006021660A1/fr
Publication of FR2873295A1 publication Critical patent/FR2873295A1/fr
Application granted granted Critical
Publication of FR2873295B1 publication Critical patent/FR2873295B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A61K36/428—Trichosanthes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/84—Valerianaceae (Valerian family), e.g. valerian
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0408230A 2004-07-26 2004-07-26 Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation Expired - Lifetime FR2873295B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0408230A FR2873295B1 (fr) 2004-07-26 2004-07-26 Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation
EP05790724A EP1786384A1 (fr) 2004-07-26 2005-07-20 Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation
US11/572,769 US20080045594A1 (en) 2004-07-26 2005-07-20 Use of at Least One Conjugated Triene-Containing Fatty Acid for Preparing a Medicine for Treating Inflammation
PCT/FR2005/001859 WO2006021660A1 (fr) 2004-07-26 2005-07-20 Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0408230A FR2873295B1 (fr) 2004-07-26 2004-07-26 Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation

Publications (2)

Publication Number Publication Date
FR2873295A1 FR2873295A1 (fr) 2006-01-27
FR2873295B1 true FR2873295B1 (fr) 2006-12-01

Family

ID=34949333

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0408230A Expired - Lifetime FR2873295B1 (fr) 2004-07-26 2004-07-26 Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation

Country Status (4)

Country Link
US (1) US20080045594A1 (fr)
EP (1) EP1786384A1 (fr)
FR (1) FR2873295B1 (fr)
WO (1) WO2006021660A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
CA2704371A1 (fr) * 2007-11-01 2009-05-07 Wake Forest University School Of Medicine Compositions et procedes de prevention et de traitement de maladies touchant des mammiferes
FR2929515B1 (fr) * 2008-04-08 2014-03-07 Lr Beva Utilisation d'acides gras comprenant un diene conjugue n-5cis, n-7trans ou un triene conjugue n-5cis, n-7trans, n-9cis en tant que medicament
GB0814105D0 (en) * 2008-08-01 2008-09-10 Springdale Sustainable Develop Composition for accelerated production of collagen
CA2740213A1 (fr) * 2008-10-24 2010-04-29 Unilever Plc Composition topique renfermant des extraits de a. indicia et m. charantia ou s. indicium
GB0902040D0 (en) * 2009-02-06 2009-03-11 Seeds Lp Composition for treatment of skin
FR2949044B1 (fr) 2009-08-12 2021-05-07 Expanscience Lab Composition comprenant une fraction d'insaponifiable
KR100985719B1 (ko) 2009-09-15 2010-10-06 (주)지에프씨 노나무와 무궁화 추출물을 유효성분으로 하는 화장료 조성물
FR2984730A1 (fr) * 2011-12-22 2013-06-28 Diverchim Nouvelles compositions cosmetiques anti-age et depigmentantes
IT201700037319A1 (it) 2017-04-05 2018-10-05 Moss S P A Composizione naturale per uso in ginecologia
ES3003660T3 (en) 2017-11-22 2025-03-10 Organicare Llc Method for the production of an ozonized olive oil

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU616502B2 (en) * 1988-04-22 1991-10-31 Medvet Science Pty. Ltd. Treatment of inflammatory disorders in humans
FR2762512B1 (fr) * 1997-04-24 2000-10-13 Pharmascience Lab Compositions a base d'huile de lupin, notamment a base d'huile de lupin et d'huile de germe de ble et leur utilisation en cosmetologie, en pharmacie et en tant que complement alimentaire
US6964786B1 (en) * 1999-07-15 2005-11-15 Pushpa Khanna Oil from Momordica charantia L., its method of preparation and uses
FR2798667B1 (fr) * 1999-09-22 2001-12-21 Pharmascience Lab Procede d'extraction des composes furaniques et alcools gras polyhydroxyles de l'avocat, composition a base de et utilisation de ces composes en therapeutique, cosmetique et alimentaire
WO2001085968A2 (fr) * 2000-05-09 2001-11-15 Bioriginal Food & Science Corp. Production d'acides linoleiques et d'acides linoleiques conjugues dans des plantes
KR100858768B1 (ko) * 2001-06-21 2008-09-16 교와 핫꼬 고교 가부시끼가이샤 식물체 분말 함유 식물 추출물의 제조 방법
FR2826579B1 (fr) * 2001-06-29 2005-08-05 Pharmascience Lab Composition cosmetique contenant au moins une huile extraite de graines de cucurbitacees, son utilisation cosmetique, therapeutique et alimentaire
DE10158046A1 (de) * 2001-11-27 2003-06-05 Basf Ag Formulierung für den Einsatz in Lebensmitteln, Nahrungsergänzungsmitteln, Futtermitteln, Futterzusatzstoffen, pharmazeutischen und kosmetischen Zubereitungen sowie Verfahren zu deren Herstellung
CA2486967A1 (fr) * 2002-05-24 2003-12-04 Neopharm, Inc. Compositions de cardiolipine, leurs procedes de preparation et d'utilisation
US20040235925A1 (en) * 2002-12-17 2004-11-25 Pharmacia Corporation Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of duloxetine, venlafaxine or atomoxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof

Also Published As

Publication number Publication date
WO2006021660A1 (fr) 2006-03-02
EP1786384A1 (fr) 2007-05-23
US20080045594A1 (en) 2008-02-21
WO2006021660A8 (fr) 2006-04-27
FR2873295A1 (fr) 2006-01-27

Similar Documents

Publication Publication Date Title
FR15C0069I2 (fr) Formulation a usage topique d'ivermectine pour le traitement de conditions dermatologiques
EP2036565A4 (fr) Préparation pour application cutanée contenant de l'acide triterpénique
FR2873295B1 (fr) Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation
FR2878747B1 (fr) Utilisation d'acide(s) gras omega-3 pour le traitement de l'hypercholesterolemie causee par un traitement anti-retroviral chez les patients infectes par le vih
EP2255804A4 (fr) Composition pharmaceutique et son utilisation dans la préparation d'un médicament pour le traitement de maladies vasculaires cérébrales
EP2255822A4 (fr) Utilisation de la section efficace d'alcaloïdes provenant de ramulus mori dans la préparation d'un agent hypoglycémiant
ITMI20020756A1 (it) Composizioni farmaceutiche topiche per il trattamento delle dermatiti
EP1971372A4 (fr) Compositions de supports a noyau hydrophobe pour l'administration d'agents therapeutiques, et procedes de preparation et d'utilisation
EP2187900A4 (fr) Composition thérapeutique pour le traitement de l'inflammation des annexes et des tissus oculaires
EP1883416A4 (fr) Compositions et procedes pour la prevention et le traitement de conditions associees a l'inflammation
IL221764A (en) Use of bile acid sulfate to make pharmaceutical preparations for the treatment of fxr-related diseases
EA201101243A1 (ru) 3h-имидазо[4,5-c]пиридин-6-карбоксамиды в качестве противовоспалительных средств
EP1986652A4 (fr) Aminotétrahydropyrannes en tant qu'inhibiteurs de dipeptidylpeptidase-iv dans le traitement prophylactique ou thérapeutique du diabète
EP2029164A4 (fr) Thérapie de recrutement anti-leucocytaire pour le traitement de crises épileptiques et de l'épilepsie
AU2002216897A1 (en) Pharmaceutical combination for the treatment of tissue damage owing to an arterial irrigation defect
EP2301560A4 (fr) Agent pharmaceutique pour favoriser la régénération fonctionnelle d'un tissu lésé
EP1807146A4 (fr) Composition pour l'amelioration de l'efficacite d'administration de medicaments
EP2200443A4 (fr) Acides gras à chaîne ramifiée pour la prévention ou le traitement de troubles gastro-intestinaux
FR13C0044I2 (fr) Utilisation de dihydroimidazolones pour le traitement de l'epilepsie canine
FR2891460B1 (fr) Utilisation d'au moins un compose de la famille des avermectines pour le traitement des pathologies ophtalmiques dues au demodex folliculorum.
FR2939667B1 (fr) Composition d'immunoglobine g comme medicament pour le traitement de l'ictere neonatal par incompatibilite foetomaternelle dans le systeme abo
EP1581243A4 (fr) Lactoferrine orale pour le traitement des sepsies
FR2900157B1 (fr) Procede de desulfuration d'essences olefiniques comprenant au moins deux etapes distinctes d'hydrodesulfuration
FR2918993B1 (fr) Utilisation de diesters d'acide carboxylique pour le traitement de textiles et formulation.
FR2926455B1 (fr) Implant pour le traitement de l'incontinence urinaire a l'effort chez la femme

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20